Quality indicators for management of osteoporosis [4]

Annals of Internal Medicine

Volumn 137, Issue 7, 2002, Pages 621-622

  Bauer, Douglas C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; TESTOSTERONE;

BONE DENSITY; BONE MASS; ELDERLY CARE; HEALTH CARE QUALITY; HUMAN; HYPOGONADISM; LETTER; OSTEOPOROSIS; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

EID: 0036787977     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-137-7-200210010-00022     Document Type: Letter

References (5)

1. Grossman JM, MacLean CH. Quality indicators for the management of osteoporosis in vulnerable elders. Ann Intern Med. 2001;135:722-30. [PMID: 11601955]
2. Amin S, Zhang Y, Sawin CT, Evans SR, Hannan MT, Kiel DP, et al. Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med. 2000;133:951-63. [PMID: 11119396]
3. Khosla S, Melton LJ 3rd, Atkinson EJ, O'Fallon WM. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab. 2001;86:3555-61. [PMID: 11502778]
4. Report of National Institute on Aging Advisory Panel on Testosterone Replacement in Men. J Clin Endocrinol Metab. 2001;86:4611-4. [PMID: 11600511]
5. Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000;343:604-10. [PMID: 10979796]